Clinical Trial

BioHPP and Lithium Disilicate Onlay Restorations: Clinical Evaluation

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
In this study, clinical data obtained from the in vivo evaluation of onlay restorations fabricated with CAD/CAM using modified PEEK (BioHPP Shade 2, Bredent group GmbH \& Co. KG, Senden, Germany) and lithium disilicate (IPS e.max CAD, Ivoclar Vivadent, Schaan, Liechtenstein) ceramic materials will be analyzed, and the clinical outcomes will be assessed to investigate the clinical applicability of BioHPP. The clinical success of the restorations will be evaluated using established clinical evaluation criteria, specifically the modified United States Public Health Service (USPHS) criteria, focusing on parameters such as marginal adaptation, surface roughness, color match, anatomical form, and participant-reported outcomes. These restorations will be applied to molar teeth in the maxilla and mandible, provided that the teeth are vital and have no adjacent or opposing restorations. Only teeth meeting these inclusion criteria will be considered in the study.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-19; most recent amendment 2025-11-13.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-11-13
Trial Details
NCT Number NCT07142031
Lead Sponsor Ege University
Collaborators: The Scientific and Technological Research Council of Turkey
Conditions Dental Caries, Polymers
Enrollment 40 participants
Start Date 2025-09-15
Primary Completion 2026-09-15 (estimated)
Study Completion 2026-10-15 (estimated)
Updated on ClinicalTrials.gov 2025-11-14